Sma News & Perspectives
Spinraza’s Benefits Mild, Transient in Infant With Severe Type 0 SMA
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:05:21
- Mas informaciones
Informações:
Sinopsis
SMA News Today’s multimedia associate, Price Wooldridge, discusses the mild, transient benefits of Spinraza treatment in an infant with severe, Type 0, Spinal Muscular Atrophy (SMA). Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/
